(Total Views: 645)
Posted On: 09/26/2022 10:11:09 PM
Post# of 148899
I read your post this morning. Loved it. Agreed with it completely.
I loved the way you made a distinction between the shorts and the traders. That was great.
I feel like tomorrow could be big.
There are many reasons why a Press Release could be made tomorrow.
Not just any ordinary press release mind you.
You just may get your wish Riz.
See below quote from Pitt on YMB.
I loved the way you made a distinction between the shorts and the traders. That was great.
I feel like tomorrow could be big.
There are many reasons why a Press Release could be made tomorrow.
Not just any ordinary press release mind you.
You just may get your wish Riz.
See below quote from Pitt on YMB.
Quote:
All longs if you look at the last week of events; Cyrus gets 1.59 million shares of CYDY stock, today's S3 registration info to the SEC, the FDA warning on the Cydy site removed! looks like something big is happening all a few days prior to the CC. Just FYI a material event i.e. if Cyrus did something to earn those 1.59 million shares it has to be made known to the shareholders within 4 business days. So that's tomorrow or Wednesday based on how they calculate the time of the event. Add that to all the trial data info that was supposed to come out in August and September. The thing I find interesting is the share price has been a non-event to management. The BLA is a rolling BLA so if safety data has been submitted to release hold it could be good enough to allow BLA approval. Not to mention DR Kelly's book coming out at the same time. So if we get a PR for a buyout or partnership tomorrow I wouldn't be surprised. But if no PR prior to the CC then it may just be an update on the hold and trials. I don't feel that's the case. Just something else that's interesting. Today GSK announced their CFO is retiring in April and they are replacing him with an experienced prior Roche and Aztra Zeneca experienced finance person. Why is that important? I've always thought that GSK would be primary on mTNB cure. They have a female CEO and now will be getting a female CFO and if they acquire Cydy does Tanya go there or Burke,? What a great time to announce GSK is acquiring Leronlimab to move to cure breast cancer than to announce it just before or in breast cancer awareness month OCT.
Lots of things could happen in the next 2 days but at least we know something is going on with the recent events. I'm excited as usual but this feels different.
(1)
(0)
Scroll down for more posts ▼